Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Assets (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Non-Current Assets for 5 consecutive years, with $565.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 75.84% year-over-year to $565.5 million, compared with a TTM value of $1.9 billion through Dec 2025, down 17.2%, and an annual FY2025 reading of $202000.0, down 98.6% over the prior year.
  • Non-Current Assets was $565.5 million for Q4 2025 at Roivant Sciences, up from $551.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.3 billion in Q4 2024 and bottomed at $202000.0 in Q1 2025.
  • Average Non-Current Assets over 5 years is $628.5 million, with a median of $507.3 million recorded in 2022.
  • The sharpest move saw Non-Current Assets skyrocketed 257.11% in 2023, then plummeted 98.6% in 2025.
  • Year by year, Non-Current Assets stood at $397.1 million in 2021, then soared by 40.2% to $556.7 million in 2022, then surged by 257.11% to $2.0 billion in 2023, then grew by 17.73% to $2.3 billion in 2024, then plummeted by 75.84% to $565.5 million in 2025.
  • Business Quant data shows Non-Current Assets for ROIV at $565.5 million in Q4 2025, $551.0 million in Q3 2025, and $416.9 million in Q2 2025.